Government urged to support research-oriented pharmaceutical firms

Published: 2008-12-18 07:00:00

Updated: 2008-12-18 07:00:00

The government needs to boost research-oriented pharmaceutical companies’ effort to develop new drugs by forging a special team, according to the Korea Drug Research Association.

The Korea-U.S. FTA will provide a chance for these pharmaceutical companies to adapt themselves to an advanced syst...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK